Have you got a telephone directory? article rewriting service Prosensa and Glaxo are competing against Sarepta Therapeutics Inc in a race to bring the first DMD drug to market, and drisapersen, with its recently acquired "breakthrough" status, could move ahead in the regulatory review process.